Related Experiment Video

Updated: Oct 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1

P Storz1, H Döppler, K Pfizenmaier

  • 1Institute of Cell Biology, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany. peter.storz@po.uni-stuttgart.de

FEBS Letters
|January 5, 2000
PubMed

Insights

Insulin directly activates STAT5b in rhabdomyosarcoma cells via the insulin receptor kinase, not JAK2. This selective phosphorylation highlights STAT5b as a key target in insulin signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Signal transducer and activator of transcription (STAT) proteins regulate gene expression in response to cytokines and growth factors.
  • STAT5 activation is typically mediated by Janus kinases (JAKs), particularly JAK2, but direct activation by the insulin receptor kinase is emerging.
  • STAT5 comprises two highly similar isoforms: STAT5a and STAT5b.

Purpose of the Study:

  • To investigate the direct activation of STAT5 isoforms by the insulin receptor kinase.
  • To determine the role of JAK2 versus the insulin receptor kinase in insulin-induced STAT5 activation in Kym-1 cells.
  • To elucidate the specific STAT5 isoform targeted by insulin signaling.

Main Methods:

  • Utilized Kym-1 cells, a rhabdomyosarcoma cell line.
  • Administered insulin and specific inhibitors: HNMPA-(AM)(3) for insulin receptor kinase and tyrphostin AG490 for JAK2.
  • Assessed tyrosine phosphorylation of STAT5a and STAT5b using Western blotting or similar techniques.

Main Results:

  • Insulin induced selective tyrosine phosphorylation of STAT5b in Kym-1 cells.
  • Inhibition of the insulin receptor kinase abolished insulin-induced STAT5b phosphorylation.
  • JAK2 inhibition did not affect insulin-induced STAT5b phosphorylation, while IFNgamma-induced STAT5b activation remained JAK2-dependent.

Conclusions:

  • STAT5b, but not STAT5a, is a direct downstream target of the insulin receptor kinase in this rhabdomyosarcoma model.
  • This finding differentiates the signaling pathways for insulin and JAK-dependent cytokines on STAT5b activation.
  • Highlights a novel role for the insulin receptor kinase in STAT5b regulation.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...